AR056791A1 - Cepa de staphylococcus aureus - Google Patents

Cepa de staphylococcus aureus

Info

Publication number
AR056791A1
AR056791A1 ARP060104905A ARP060104905A AR056791A1 AR 056791 A1 AR056791 A1 AR 056791A1 AR P060104905 A ARP060104905 A AR P060104905A AR P060104905 A ARP060104905 A AR P060104905A AR 056791 A1 AR056791 A1 AR 056791A1
Authority
AR
Argentina
Prior art keywords
staphylococcus aureus
aureus strain
strain
reynolds
genetic engineering
Prior art date
Application number
ARP060104905A
Other languages
English (en)
Inventor
Chia Y Lee
Thanh T Luong
Original Assignee
Univ Arkansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38068033&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR056791(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Arkansas filed Critical Univ Arkansas
Publication of AR056791A1 publication Critical patent/AR056791A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/44—Staphylococcus
    • C12R2001/445—Staphylococcus aureus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Cepa de Staphylococcus Aureus que a través de ingeniería genética produce polisacáridos capsulares tipo 5 en mayores niveles que la cepa de Staphylococcus Aureus de Reynolds.
ARP060104905A 2005-11-21 2006-11-09 Cepa de staphylococcus aureus AR056791A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/285,700 US7521221B2 (en) 2005-11-21 2005-11-21 Staphylococcus aureus strain CYL1892

Publications (1)

Publication Number Publication Date
AR056791A1 true AR056791A1 (es) 2007-10-24

Family

ID=38068033

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104905A AR056791A1 (es) 2005-11-21 2006-11-09 Cepa de staphylococcus aureus

Country Status (8)

Country Link
US (2) US7521221B2 (es)
EP (1) EP1951887B1 (es)
AR (1) AR056791A1 (es)
AT (1) ATE555211T1 (es)
AU (1) AU2006318271B2 (es)
CA (1) CA2629488A1 (es)
NZ (2) NZ568164A (es)
WO (1) WO2007062366A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521221B2 (en) * 2005-11-21 2009-04-21 Board Of Trustees Of The University Of Arknasas Staphylococcus aureus strain CYL1892
FR2899110A1 (fr) * 2006-03-31 2007-10-05 Sanofi Pasteur Sa Polysaccharides capsulaires de type 5 et de type 8 des souches surproductrices de staphylococcus aureus
EP2705141A1 (en) * 2011-05-02 2014-03-12 FrieslandBrands B.V. Probiotics with enhanced survival properties
CN114480387B (zh) * 2022-01-05 2023-08-25 四川大学华西医院 一种金黄色葡萄球菌组成型启动子、表达载体及其构建方法、重组菌株及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US6593114B1 (en) * 1996-01-05 2003-07-15 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences
AU729377B2 (en) 1997-10-23 2001-02-01 Asterias Biotherapeutics, Inc. Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
DE69936720T2 (de) 1998-05-29 2008-04-30 Osiris Therapeutics, Inc. Menschliche cd45+ und/oder fibroblasten+ mesenchymale stammzellen
JP4526186B2 (ja) 1998-06-08 2010-08-18 オシリス セラピューティクス，インコーポレイテッド 造血幹細胞を試験管内で維持する方法と組成物
RU2249039C2 (ru) 1999-02-04 2005-03-27 Текнион Рисерч Энд Дивелопмент Фаундейшн Лтд. Способ размножения/поддержания недифференцированных гемопоэтических стволовых клеток или клеток-предшественников (варианты), способ приготовления кондиционированной среды стромальных клеток, способ трансплантации недифференцированных гемопоэтических стволовых клеток или клеток-предшественников (варианты)
US7326571B2 (en) 2003-07-17 2008-02-05 Boston Scientific Scimed, Inc. Decellularized bone marrow extracellular matrix
FR2884830A1 (fr) * 2005-04-25 2006-10-27 Sanofi Pasteur Sa Procede de production de souches de staphylococcus aureus surproductrices
US7521221B2 (en) * 2005-11-21 2009-04-21 Board Of Trustees Of The University Of Arknasas Staphylococcus aureus strain CYL1892
FR2899110A1 (fr) * 2006-03-31 2007-10-05 Sanofi Pasteur Sa Polysaccharides capsulaires de type 5 et de type 8 des souches surproductrices de staphylococcus aureus

Also Published As

Publication number Publication date
US7521221B2 (en) 2009-04-21
NZ590409A (en) 2011-04-29
WO2007062366A3 (en) 2008-08-14
AU2006318271A1 (en) 2007-05-31
EP1951887A4 (en) 2009-04-15
NZ568164A (en) 2011-05-27
US20070166803A1 (en) 2007-07-19
US8097446B2 (en) 2012-01-17
AU2006318271B2 (en) 2012-05-10
EP1951887B1 (en) 2012-04-25
US20100184160A1 (en) 2010-07-22
WO2007062366A2 (en) 2007-05-31
EP1951887A2 (en) 2008-08-06
ATE555211T1 (de) 2012-05-15
CA2629488A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
MY144643A (en) Space structure
AR110313A2 (es) Derivados de tiazol-2-il-pirrolidina
BR112015014562A2 (pt) composições pesticidas e processos com estas relacionados
RS52784B (en) They're TANATE RAZAGILINA
JP2006287194A5 (es)
ES2354696T8 (es) Planta que produce ácido hialurónico.
EA200702529A1 (ru) Фунгицидная комбинация биологически активных веществ
ATE540705T1 (de) Überzüge und artikel mit natürlichen biologisch abbaubaren polysacchariden
EA201000888A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов
DE602007009284D1 (de) 3-aza-bicycloä3.1.0ühexanderivate
TW200730490A (en) Photoactive compounds
BRPI0803076A2 (pt) composição microbicida
JP2008050558A5 (es)
HN2005035436A (es) Caja de empaque
IL190158A0 (en) Plant pathogenic defence increase
UA45061S (uk) 1. футляр
UY31688A1 (es) Plaguicidas
GT200900031A (es) Aplicacion por via transdermica de triazinas para combatir infecciones por coccidios
AR056791A1 (es) Cepa de staphylococcus aureus
CO6251376A2 (es) Triazolilpiridina cetonas herbicidas
CL2008002704A1 (es) Composicion herbicida que comprende un compuesto derivado de 1,4-dihidro-2h-piridazin-3-ona.
HN2005035435A (es) Caja de empaque
JP2012513655A5 (es)
HN2005035437A (es) Caja de empaque
JPWO2021193448A5 (es)

Legal Events

Date Code Title Description
FG Grant, registration
FG Grant, registration